Tivic Health™ Systems Inc. today announced that, ClearUP® Sinus Pain Relief, a game-changing treatment for sinus pain due to allergic rhinitis, has been named a finalist at the Health 2.0 Annual Launch! competition.
| SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- Tivic Health™ Systems Inc. today announced that, ClearUP® Sinus Pain Relief, a game-changing treatment for sinus pain due to allergic rhinitis, has been named a finalist at the Health 2.0 Annual Launch! competition. Health 2.0 will take place September 16-18 at Santa Clara Convention Center and the Launch! competition will take place on Wednesday afternoon, September 18. Launch! is a Health 2.0 original program that selects eight new companies to debut their health tech innovation on stage. Over the past 11 years, Health 2.0 has debuted over 120 companies to the ecosystem. ClearUP, a small, hand-held device for home use, is the first sinus treatment that uses gentle microcurrent waveforms to reduce allergy-related sinus pain. Forty to 60 million Americans suffer from allergic rhinitis and over 90 percent report sinus pain. Tivic Health received Class II medical device clearance for ClearUP from the FDA in January 2019. Clinically proven and priced at $149, ClearUP will be available for purchase over-the-counter at www.tivichealth.com beginning September 16 and at Amazon on September 30. “We are looking forward to demonstrating ClearUP at Launch! and discussing the benefits that bioelectronic medicine is having on the delivery of health care services to patients with chronic conditions,” said Jennifer Ernst, CEO and co-founder of Tivic Health. “ClearUP uses the power of neuromodulation to deliver a drug free treatment for sinus pain without chemical side effects.” About ClearUP Sinus Pain Relief About Tivic Health Systems Inc.
SOURCE Tivic Health Systems Inc. |
View original content:
